<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">03416</article-id><article-id pub-id-type="doi">10.7554/eLife.03416</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Immunology and Inflammation</subject></subj-group></article-categories><title-group><article-title>Epigenetic modification of the PD-1 (<italic>Pdcd1</italic>) promoter in effector CD4<sup>+</sup> T cells tolerized by peptide immunotherapy</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-14546"><name><surname>McPherson</surname><given-names>Rhoanne C</given-names></name><aff><institution content-type="dept">MRC Centre for Inflammation Research</institution>, <institution>University of Edinburgh</institution>, <addr-line><named-content content-type="city">Edinburgh</named-content></addr-line>, <country>United Kingdom</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-14547"><name><surname>Konkel</surname><given-names>Joanne E</given-names></name><aff><institution content-type="dept">MRC Centre for Inflammation Research</institution>, <institution>University of Edinburgh</institution>, <addr-line><named-content content-type="city">Edinburgh</named-content></addr-line>, <country>United Kingdom</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-14548"><name><surname>Prendergast</surname><given-names>Catriona T</given-names></name><aff><institution content-type="dept">MRC Centre for Inflammation Research</institution>, <institution>University of Edinburgh</institution>, <addr-line><named-content content-type="city">Edinburgh</named-content></addr-line>, <country>United Kingdom</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-14554"><name><surname>Thomson</surname><given-names>John P</given-names></name><aff><institution content-type="dept">MRC Human Genetics Unit, Institute of Genetics and Molecular Medicine</institution>, <institution>University of Edinburgh</institution>, <addr-line><named-content content-type="city">Edinburgh</named-content></addr-line>, <country>United Kingdom</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-14553"><name><surname>Ottaviano</surname><given-names>Raffaele</given-names></name><aff><institution content-type="dept">MRC Human Genetics Unit, Institute of Genetics and Molecular Medicine</institution>, <institution>University of Edinburgh</institution>, <addr-line><named-content content-type="city">Edinburgh</named-content></addr-line>, <country>United Kingdom</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-14549"><name><surname>Leech</surname><given-names>Melanie D</given-names></name><aff><institution content-type="dept">MRC Centre for Inflammation Research</institution>, <institution>University of Edinburgh</institution>, <addr-line><named-content content-type="city">Edinburgh</named-content></addr-line>, <country>United Kingdom</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-21991"><name><surname>Kay</surname><given-names>Oliver</given-names></name><aff><institution content-type="dept">MRC Centre for Inflammation Research</institution>, <institution>University of Edinburgh</institution>, <addr-line><named-content content-type="city">Edinburgh</named-content></addr-line>, <country>United Kingdom</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-14550"><name><surname>Zandee</surname><given-names>Stephanie E J</given-names></name><aff><institution content-type="dept">MRC Centre for Inflammation Research</institution>, <institution>University of Edinburgh</institution>, <addr-line><named-content content-type="city">Edinburgh</named-content></addr-line>, <country>United Kingdom</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-14551"><name><surname>Sweenie</surname><given-names>Claire H</given-names></name><aff><institution content-type="dept">MRC Centre for Inflammation Research</institution>, <institution>University of Edinburgh</institution>, <addr-line><named-content content-type="city">Edinburgh</named-content></addr-line>, <country>United Kingdom</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-3373"><name><surname>Wraith</surname><given-names>David C</given-names></name><aff><institution content-type="dept">Department of Cellular and Molecular Medicine</institution>, <institution>University of Bristol</institution>, <addr-line><named-content content-type="city">Bristol</named-content></addr-line>, <country>United Kingdom</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-14555"><name><surname>Meehan</surname><given-names>Richard R</given-names></name><aff><institution content-type="dept">MRC Human Genetics Unit, Institute of Genetics and Molecular Medicine</institution>, <institution>University of Edinburgh</institution>, <addr-line><named-content content-type="city">Edinburgh</named-content></addr-line>, <country>United Kingdom</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-14552"><name><surname>Drake</surname><given-names>Amanda J</given-names></name><aff><institution content-type="dept">Endocrinology Unit</institution>, <institution>University of Edinburgh</institution>, <addr-line><named-content content-type="city">Edinburgh</named-content></addr-line>, <country>United Kingdom</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-14165"><name><surname>Anderton</surname><given-names>Stephen M</given-names></name><aff><institution content-type="dept">MRC Centre for Inflammation Research</institution>, <institution>University of Edinburgh</institution>, <addr-line><named-content content-type="city">Edinburgh</named-content></addr-line>, <country>United Kingdom</country><email>steve.anderton@ed.ac.uk</email></aff><xref ref-type="fn" rid="conf1"/></contrib></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-1178"><name><surname>Sakaguchi</surname><given-names>Shimon</given-names></name><role>Reviewing editor</role><aff><institution>Osaka University</institution>, <country>Japan</country></aff></contrib></contrib-group><pub-date date-type="pub" publication-format="electronic"><day>29</day><month>12</month><year>2014</year></pub-date><volume>3</volume><elocation-id>e03416</elocation-id><supplementary-material><ext-link xlink:href="elife-03416-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material><history><date date-type="received"><day>19</day><month>05</month><year>2014</year></date><date date-type="accepted"><day>24</day><month>12</month><year>2014</year></date></history><permissions><copyright-statement>Â© 2014, McPherson et al</copyright-statement><copyright-year>2014</copyright-year><copyright-holder>McPherson et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><abstract><p>Clinically effective antigen-based immunotherapy must silence antigen-experienced effector T cells (Teff) driving ongoing immune pathology. Using CD4<sup>+</sup> autoimmune Teff cells, we demonstrate that peptide immunotherapy (PIT) is strictly dependent upon sustained T cell expression of the co-inhibitory molecule PD-1. We found high levels of 5-hydroxymethylcytosine (5hmC) at the PD-1 (<italic>Pdcd1</italic>) promoter of non-tolerant T cells. 5hmC was lost in response to PIT, with DNA hypomethylation of the promoter. We identified dynamic changes in expression of the genes encoding the Ten-Eleven-Translocation (TET) proteins that are associated with the oxidative conversion 5-methylcytosine and 5hmC, during cytosine demethylation. We describe a model whereby promoter demethylation requires the co-incident expression of permissive histone modifications at the <italic>Pdcd1</italic> promoter together with TET availability. This combination was only seen in tolerant Teff cells following PIT, but not in Teff that transiently express PD-1. Epigenetic changes at the <italic>Pdcd1</italic> locus therefore determine the tolerizing potential of TCR-ligation.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group></article-meta></front><back><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: This study was approved by the University of Edinburgh Ethical Review Panel and was performed in accordance with UK legislation (PPL 60/4116).</p></fn></fn-group></back></article>